Research Fellow (Biology)

The Medicines Discovery Institute represents a major investment in translational science by Cardiff University. The goal of the Institute is to translate world-leading research on scientific understanding of disease mechanisms into innovative therapeutic approaches. Our vision is to play a leading role in discovering new medicines in areas of high unmet need, with a particular emphasis on neuroscience, mental health, and cancer. We are creating a vibrant community of researchers across both academic and biotech sectors engaged in major research programmes which build off the unique strengths of Cardiff University and work collaboratively with other universities and companies across Wales and internationally.

The Medicines Discovery Institute are looking to attract an experienced Cancer Cell Biologist to support the preclinical development of a novel PROTAC drug. The project is funded by the MRC and is full-time for 22 months. The successful candidate will have experience with handling proteomic and transcriptomic data, and working with patient-derived primary cell materials.

The role holder and the project leader will coordinate internal and external outsourced activities to ensure that the project delivers its pre-agreed milestones. The role holder will coordinate outsourced activities, including managing contract biology support activities. The holder will be vital in shaping and driving the project and securing follow on external grants and commercial investment.

In addition to the funded preclinical work, the holder will use their experience to support new oncology grant funding applications. With knowledge and experience in the principles of target identification and target validation, the role holder will design and deliver experiments that will generate the data packages that are critical in supporting the early-stage drug discovery grant applications that underpin the long-term sustainability of the institute.

The post will be based at Cardiff University and will be part of a multi-disciplinary drug discovery team. For informal inquiries, please contact [email protected] .

This position is full-time (35 hours per week), available from 1st January 2024 and fixed term until 31st October 2025. 

Secondment opportunity welcome - please note for Cardiff University members of staff interested in this post on a secondment basis, permission will need to be sought from your current Line Manager before applying.

Closing date: 29 February 2024

Cardiff University is committed to supporting and promoting equality and diversity and to creating an inclusive working environment. We believe this can be achieved through attracting, developing, and retaining a diverse range of staff from many different backgrounds. We therefore welcome applicants from all sections of the community regardless of sex, ethnicity, disability, sexual orientation, trans identity, relationship status, religion or belief, caring responsibilities, or age.  In supporting our employees to achieve a balance between their work and their personal lives, we will also consider proposals for flexible working or job share arrangements.

Cardiff University is a signatory to the San Francisco Declaration on Research Assessment (DORA), which means that in hiring and promotion decisions we will evaluate applicants on the quality of their research, not publication metrics or the identity of the journal in which the research is published. More information is available at:  Responsible research assessment - Research - Cardiff University

To apply, please click on the ‘Apply’ button above